血管生成
癌症研究
医学
胶质母细胞瘤
缺氧(环境)
细胞生物学
神经科学
信号转导
肿瘤微环境
癌症
内皮
肿瘤细胞
下调和上调
生物
双重角色
癌细胞
计算生物学
转化医学
免疫学
结合
细胞信号
生物信息学
血栓反应蛋白1
化学
作者
Y Zheng,Han Sun,Zhe Fu,Haojie Chen,Guangyao Cai,Xin Huang,Pan Y,Kai Yu,P Chen,Zhuoran Liang,Junteng Li,Jiamin Hu,Jing Shi,Shu-Hui Liu,Xun Meng,Qinian Wu,Juntong Di,Hui Luo,Rui‐Hua Xu,Zexian Liu
出处
期刊:中国科学通报:英文版
日期:2026-06-08
卷期号:71 (14): 3713-3730
标识
DOI:10.1016/j.scib.2026.06.022
摘要
Targeting angiogenesis represents a cornerstone in the development of antitumoral therapy, yet the suboptimal responses and inevitable resistance significantly limit its clinical efficacy. To better understand the mechanisms underlying anti-angiogenic resistance, this study systematically characterized the pancancer angiogenic landscape based on 1.24 million individual cells across 13 cancer types. Our analyses revealed that pericytes (PCs) and PC-derived non-classical angiogenic factors PGF/ANGPT2 correlate with angiogenesis more prominently than the classical VEGFA-centric model. Tumor-educated PCs, namely MCAM + immature PCs (imPCs), were spatio-transcriptionally identified as the primary source of PGF/ANGPT2, driving alternative angiogenesis and serving as a major contributor to ɑVEGFR resistance. MCAM + imPCs were phenotypically shaped under the dysregulated Notch signaling and hypoxia stress. To address the limitations associated with single-targeted endothelial cells (ECs) inhibition via ɑVEGFR, we adopted MCAM-directed antibody-drug conjugate (MCAM ADC) to specifically eliminate pro-angiogenic PCs, whose combination with ɑVEGFR showed enhanced anti-angiogenic effects. This dual-targeting approach demonstrated superior tumor control, offering MCAM ADC as a promising translational solution to circumvent anti-angiogenic resistance. Overall, our findings redefine the mechanisms of angiogenic resistance and suggest a dual EC/PC inhibition strategy for more effective anticancer therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI